Xu D - Search Results

1

Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).

Chan HLY, Ahn SH, Chang TT, Peng CY, Wong D, Coffin CS, Lim SG, Chen PJ, Janssen HLA, Marcellin P, Serfaty L, Zeuzem S, Cohen D, Critelli L, Xu D, Wind-Rotolo M, Cooney E; LIRA-B Study Team. Chan HLY, et al. Among authors: xu d. J Hepatol. 2016 May;64(5):1011-1019. doi: 10.1016/j.jhep.2015.12.018. Epub 2015 Dec 29. J Hepatol. 2016. PMID: 26739688 Clinical Trial.

2

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection.

Muir AJ, Arora S, Everson G, Flisiak R, George J, Ghalib R, Gordon SC, Gray T, Greenbloom S, Hassanein T, Hillson J, Horga MA, Jacobson IM, Jeffers L, Kowdley KV, Lawitz E, Lueth S, Rodriguez-Torres M, Rustgi V, Shemanski L, Shiffman ML, Srinivasan S, Vargas HE, Vierling JM, Xu D, Lopez-Talavera JC, Zeuzem S; EMERGE study group. Muir AJ, et al. Among authors: xu d. J Hepatol. 2014 Dec;61(6):1238-46. doi: 10.1016/j.jhep.2014.07.022. Epub 2014 Jul 24. J Hepatol. 2014. PMID: 25064437 Clinical Trial.

3

Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.

Santagostino E, Pol S, Olveira A, Reesink HW, van Erpecum K, Bogomolov P, Xu D, Critelli L, Srinivasan S, Cooney E. Santagostino E, et al. Among authors: xu d. Haemophilia. 2016 Sep;22(5):692-9. doi: 10.1111/hae.12947. Epub 2016 Jun 24. Haemophilia. 2016. PMID: 27339614 Clinical Trial.

4

Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.

Wu IC, Lai CL, Han SH, Han KH, Gordon SC, Chao YC, Tan CK, Sievert W, Tanwandee T, Xu D, Neo BL, Chang TT. Wu IC, et al. Among authors: xu d. Hepatology. 2010 Apr;51(4):1185-9. doi: 10.1002/hep.23424. Hepatology. 2010. PMID: 20044806 Clinical Trial.

5

Mechanisms of Hyperbilirubinemia During Peginterferon Lambda-1a Therapy for Chronic Hepatitis C Infection: A Retrospective Investigation.

Zwirtes R, Narasimhan P, Wind-Rotolo MM, Xu D, Hruska MW, Kishnani N, Colston EM, Srinivasan S. Zwirtes R, et al. Among authors: xu d. J Interferon Cytokine Res. 2016 Nov;36(11):644-651. doi: 10.1089/jir.2015.0153. Epub 2016 Oct 6. J Interferon Cytokine Res. 2016. PMID: 27710263 Clinical Trial.

6

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, Wichroski MJ, Xu D, Yang J, Wilber RB, Colonno RJ. Tenney DJ, et al. Among authors: xu d. Hepatology. 2009 May;49(5):1503-14. doi: 10.1002/hep.22841. Hepatology. 2009. PMID: 19280622

7

Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b.

Flisiak R, Kawazoe S, Znoyko O, Assy N, Gadano A, Kao JH, Lee KS, Zwirtes R, Portsmouth S, Dong Y, Xu D, Kumada H, Srinivasan S. Flisiak R, et al. Among authors: xu d. J Interferon Cytokine Res. 2016 Nov;36(11):635-643. doi: 10.1089/jir.2015.0173. Epub 2016 Jun 21. J Interferon Cytokine Res. 2016. PMID: 27327078 Clinical Trial.

8

Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study.

Yao G, Chen C, Lu W, Ren H, Tan D, Wang Y, Xu D, Liu J, Xu D, Llamoso C. Yao G, et al. Among authors: xu d. Hepatol Int. 2008 Dec;2(4):486-93. doi: 10.1007/s12072-008-9088-8. Epub 2008 Aug 30. Hepatol Int. 2008. PMID: 19669324 Free PMC article.

9

A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.

Yao GB, Fu XX, Tian GS, Xu DZ, Hao LJ, Huangfu YS, Su CX. Yao GB, et al. Among authors: xu dz. J Gastroenterol Hepatol. 2000 Oct;15(10):1165-70. doi: 10.1046/j.1440-1746.2000.02307.x. J Gastroenterol Hepatol. 2000. PMID: 11106097 Clinical Trial.

10

Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China.

Yao G, Zhou X, Xu D, Wang B, Ren H, Liu J, Xu D, Macdonald L. Yao G, et al. Among authors: xu d. Hepatol Int. 2007 Sep;1(3):373-81. doi: 10.1007/s12072-007-9016-3. Epub 2007 Oct 4. Hepatol Int. 2007. PMID: 19669332 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,036 results

Search Page

Filters